Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a study published in Clinical Cancer Research. In addition to engaging tryptophan metabolism, IDO enhances immunosuppressive factors of the complement immune system. This finding likely explains in part why immunotherapy […]
